Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LINDSTROM, T. D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeysRUTERBORIES, K. J; LINDSTROM, T. D.Drug metabolism and disposition. 1990, Vol 18, Num 5, pp 674-679, issn 0090-9556, 6 p.Article

Disposition of the aromatase inhibitor LY56110 and associated induction and inhibition studies in rats, dogs, and monkeysLINDSTROM, T. D; WHITAKER, G. W.Fundamental and applied toxicology (Print). 1987, Vol 8, Num 4, pp 595-604, issn 0272-0590Article

The pharmacokinetics of indecainide in mice, rats, dogs, and monkeysLINDSTROM, T. D; WHITAKER, G. W.Drug metabolism and disposition. 1984, Vol 12, Num 6, pp 683-690, issn 0090-9556Article

Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeysGALLICK WHITAKER, N. G; LINDSTROM, T. D.Drug metabolism and disposition. 1987, Vol 15, Num 1, pp 107-113, issn 0090-9556Article

α,β-ketoalkene reduction: a novel reduction pathway in mammalian tissuesLINDSTROM, T. D; WHITAKER, G. W.Drug metabolism and disposition. 1984, Vol 12, Num 1, pp 72-76, issn 0090-9556Article

Saturation of an α,β-unsaturated ketone: a novel xenobiotic biotransformation in mammalsLINDSTROM, T. D; WHITAKER, G. W.Xenobiotica (London. Print). 1984, Vol 14, Num 7, pp 503-508, issn 0049-8254Article

Determination of LY217332, a new 3'-quaternary ammonium cephalosporin, in plasma by solid phase column extraction and HPLCWHITAKER, G. W; LINDSTROM, T. D.Journal of liquid chromatography. 1988, Vol 11, Num 4, pp 901-912, issn 0148-3919Article

Determination of dirithromycin, LY281389 and other macrolide antibiotics by HPLC with electrochemical detectionWHITAKER, G. W; LINDSTROM, T. D.Journal of liquid chromatography. 1988, Vol 11, Num 14, pp 3011-3020, issn 0148-3919Article

In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofeloneSURAPANENI, S. S; CLAY, M. P; SPANGLE, L. A et al.Drug metabolism and disposition. 1997, Vol 25, Num 12, pp 1383-1388, issn 0090-9556Article

Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human liversLINDSTROM, T. D; HANSSEN, B. R; WRIGHTON, S. A et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 2, pp 265-269, issn 0066-4804Article

Fused bicyclic Gly-Asp β-turn mimics with specific affinity for GPIIb-IIIaFISHER, M. J; ARFSTAN, A. E; MOHR, M et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 23, pp 4875-4889, issn 0022-2623Article

Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporinsBROWN, R. F; KINNICK, M. D; KOEHLER, R. E et al.Journal of medicinal chemistry (Print). 1990, Vol 33, Num 8, pp 2114-2121, issn 0022-2623, 8 p.Article

Antiarrhythmic drugs: Verapamil, ClofiliumBAKY, S; STEINBERG, M. I; LINDSTROM, T. D et al.New drugs annual, cardiovascular drugs. 1984, Vol 2, pp 71-121, issn 0742-387XArticle

Fused bicyclic Gly-asp β-turn mimics with potent affinity for GPIIb-IIIa. Exploration of the arginine isostereFISHER, M. J; GIESE, U; RAPP, A et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 4, pp 385-389, issn 0960-894XArticle

Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models in arthritisBENDELE, A. M; BENSLAY, D. N; HOM, J. T et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 260, Num 1, pp 300-305, issn 0022-3565Article

Phenothiazine and phenoxazine derivatives of nafazatrom. In vitro evaluation as 5-lipoxygenase and iron-dependent lipid peroxidation inhibitorsYU, M. J; MCCOWAN, J. R; BERTSCH, B et al.Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 1, pp 59-62Article

Structurally novel antiarrhythmic/antioxidant quinazolinesYU, M. J; MCCOWAN, J. R; STEINBERG, M. I et al.Bioorganic & medicinal chemistry letters. 1992, Vol 2, Num 9, pp 1121-1126Article

Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replicationSTRATFORD, R. E; CLAY, M. P; LINDSTROM, T. D et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 8, pp 747-753, issn 0022-3549Article

Correlation of anti-inflammatory activity ith peak tissue rather than peak plasma levels of BF389BENDELE, A. M; RUTERBORIES, K. J; SPAETHE, S. M et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 260, Num 3, pp 1194-1198, issn 0022-3565Article

Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeysLINDSTROM, T. D; ALTHAUS, W. A; RUTERBORIES, K. J et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 252, Num 3, pp 1117-1124, issn 0022-3565Article

  • Page / 1